Cathelicidin peptide SMAP-29: Comprehensive review of its properties and potential as a novel class of antibiotics

Drug Development Research

Volumn 70, Issue 7, 2009, Pages 481-498

  Dawson, Raymond M ^a   Liu, Chun Qiang ^a  

^a DEFENCE SCIENCE AND TECHNOLOGY ORGANISATION   (Australia)

Author keywords

Antimicrobial peptide; Cytotoxicity; Hemolysis; SMAP 29

Indexed keywords

CATHELICIDIN ANTIMICROBIAL PEPTIDE SMAP 29; GLYCINE; POLYPEPTIDE ANTIBIOTIC AGENT; UNCLASSIFIED DRUG;

ANTIMICROBIAL ACTIVITY; CARBOXY TERMINAL SEQUENCE; CYTOTOXICITY; DRUG MECHANISM; DRUG STRUCTURE; HEMOLYSIS; INFECTION PREVENTION; REVIEW; STRUCTURE ACTIVITY RELATION;

EID: 70649083246     PISSN: 02724391     EISSN: 10982299     Source Type: Journal    
DOI: 10.1002/ddr.20329     Document Type: Review

References (76)

1. Andra J, Monreal D, Martinez de Tejada G, Olak C, Brezesinski G, Gomez S, Goldmann T, Bartels R, Brandenburg K, Moriyon I. 2007. Rationale for the design of shortened derivatives of the NK-lysin-derived antimicrobial peptide NK-2 with improved activity against Gram-negative pathogens. J Biol Chem 282:14719-14728. (Pubitemid 47093359)
2. Arcidiacono S, Pivarnik P, Mello CM, Senecal A. 2008. Cy5 labeled antimicrobial peptides for enhanced detection of Escherichia coli O157:H7. Biosensors Bioelectronics 23:1721-1727.
3. Anderson RC, Hancock REW, Yu P-L. 2004a. Antimicrobial activity and bacterial-membrane interaction of ovine-derived cathelicidins. Antimicrob Agents Chemother 48:673-676.
4. Anderson RC, Haverkamp RG, Yu P-L. 2004b. Investigation of morphological changes to Staphylococcus aureus induced by ovine-derived antimicrobial peptides using TEM and AFM. FEMS Microbiol Lett 240:105-110.
5. Arzese A, Skerlavaj B, Tomasinsig L, Gennaro R, Zanetti M. 2003. Antimicrobial activity of SMAP-29 against the Bacteroides fragilis group and clostridia. J Antimicrob Chemother 52:375-381. (Pubitemid 37120715)
6. Bagella L, Scocchi M, Zanetti M. 1995. cDNA sequences of three sheep myeloid cathelicidins. FEBS Lett 376:225-228.
7. Barak O, Treat JR, James WD. 2005. Antimicrobial peptides: effectors of innate immunity in the skin. Adv Dermatol 21:357-374. (Pubitemid 41826758)
8. Bartlett KH, McCray PB, Thorne PS. 2004. Reduction in the bactericidal activity of selected cathelicidin peptides by bovine calf serum or exogenous endotoxin. Int J Antimicrob Agents 23:606-612.
9. Benincasa M, Scocchi M, Pacor S, Tossi A, Nobili D, Basaglia G, Busetti M, Gennaro R. 2006. Fungicidal activity of five cathelicidin peptides against clinically isolated yeasts. J Antimicrob Chemother 58:950-959.
10. Boman HG. 2003. Antibacterial peptides: basic facts and emerging concepts. J Intern Med 254:197-215.
11. Brogden KA. 2005. Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? Nat Rev Microbiol 3:238-250.
12. Brogden KA, Kalfa VC, Ackerman MR, Palmquist DE, McCray PB, Tack BF. 2001. The ovine cathelicidin SMAP29 kills ovine respiratory pathogens in vitro and in an ovine model of pulmonary infection. Antimicrob Agents Chemother 45:331-334.
13. Brogden KA, Ackermann M, McCray PB, Tack BF. 2003. Antimicrobial peptides in animals and their role in host defenses. Int J Antimicrob Agents 22:465-478. (Pubitemid 37356946)
14. Brogden KA, Nordholm G, Ackermann M. 2007. Antimicrobial activity of cathelicidins BMAP28, SMAP28, SMAP29, and PMAP23 against Pasteurella multocida is more broad-spectrum than host species specific. Vet Microbiol 119:76-81. (Pubitemid 44879856)
15. Chan DI, Prenner EJ, Vodel HJ. 2006. Tryptophan- and arginine-rich antimicrobial peptides: structures and mechanisms of action. Biochim Biophys Acta 1758:1184-1202.
16. Chou H-T, Kuo T-Y, Chiang J-C, Pei M-J, Yang W-T, Yu H-C, Lin S-B, Chen W-J. 2008. Design and synthesis of cationic antimicrobial peptides with improved activity and selectivity against Vibrio spp. Int J Antimicrob Agents 32:130-138.
17. Conlon JM, Galadari S, Raza H, Condamine E. 2008. Design of potent, non-toxic antimicrobial agents based upon the naturally occurring frog skin peptides, ascaphin-8 and peptide XT-7. Chem Biol Drug Des 72:58-64. (Pubitemid 351852774)
18. Dathe M, Wieprecht T, Nikolenko H, Handel L, Maloy L, MacDonald DL, Beyermann M, Bienert M. 1997. Hydrophobicity, hydrophobic moment and angle subtended by charged residues modulate antibacterial and hemolytic activity of amphipathic helical peptides. FEBS Lett 403:208-212. (Pubitemid 27081496)
19. Dawson RM, Liu C-Q. 2008. Properties and applications of antimicrobial peptides in biodefense against biological warfare agents. Crit Rev Microbiol 34:89-107.
20. Donati M, Di Leo KD, Benincasa M, Cavrini F, Accardo S, Moroni A, Gennaro R, Cevenini R. 2005. Activity of cathelicidin peptides against Chlamydia spp. Antimicrob Agents Chemother 49:1201-1202. (Pubitemid 40327748)
21. Donati M, Di Francesco A, Gennaro R, Benincasa M, Magnino S, Pignanelli S, Shurdi A, Moroni A, Mazzoni C, Merialdi G, Baldelli R, Cevenini R. 2007. Sensitivity of Chlamydia suis to cathelicidin peptides. Vet Microbiol 123:269-273. (Pubitemid 46898704)
22. Eisenberg D, Schwarz E, Komaromy M, Wall R. 1984. Analysis of membrane and surface protein sequences with the hydrophobic moment plot. J Mol Biol 179:125-142. (Pubitemid 16223392)
23. Franzman MR, Burnell KK, Dehkordi-Vakil FH, Guthmiller JM, Dawson DV, Brogden KA. 2009. Targeted antimicrobial activity of a specific IgG-SMAP28 conjugate against Porphyromonas gingivalis in a mixed culture. Int J Antimicrob Agents 33:14-20.
24. Gennaro R, Zanetti M. 2000. Structural features and biological activities of the cathelicidin-derived antimicrobial peptides. Biopolymers (Pept Sci) 55:31-49.
25. Giacometti A, Cirioni O, Simona M, Prete D, Skerlavaj B, Circo R, Zanetti M, Scalise G. 2003. In vitro effect on Cryptosporidium parvum of short-term exposure to cathelicin peptides. J Antimicrob Chemother 51:843-847.
26. Giacometti A, Cirioni O, Ghiselli R, Mocchegiani F, D'Amato G, Circo R, Orlando F, Skerlavaj B, Silvestri C, Saba V, Zanetti M, Scalise G. 2004. Cathelicidin peptide sheep myeloid antimicrobial peptide-29 prevents endotoxin-induced mortality in rat models of septic shock. Am J Respir Crit Care Med 169:187-194. (Pubitemid 38114533)
27. Giangaspero A, Sandri L, Tossi A. 2001. Amphipathic α helical antimicrobial peptides. Eur J Biochem 268:5589-5600.
28. Guthmiller JM, Vargas KG, Srikantha R, Schomberg LL, Weistroffer PL, McCray PB, Tack BF. 2001. Susceptibilities of oral bacteria and yeast to mammalian cathelicidins. Antimicrob Agents Chemother 45:3216-3219. (Pubitemid 32988855)
29. Herasimenka Y, Benincasa M, Mattiuzzo M, Cescutti P, Gennaro R, Rizzo R. 2005. Interaction of antimicrobial peptides with bacterial polysaccharides from lung pathogens. Peptides 26:1127-1132. (Pubitemid 40798068)
30. Ingham AB, Moore RJ. 2007. Recombinant production of antimicrobial peptides in heterologous microbial systems. Biotechnol Appl Biochem 47:1-9.
31. Ingham A, Sproat KW, Tizard MLV, Moore RJ. 2005. A versatile system for the expression of nonmodified bacteriocins in Escherichia coli. J Appl Microbiol 98:676-683. (Pubitemid 40349294)
32. Jin F, Xu X, Wang L, Zhang W, Gu D. 2006. Expression of recombinant hybrid peptide cecropin A [1-8]-magainin 2 [1-12] in Pichia pistoris: purification and characterization. Prot Expr Purif 50:147-156. (Pubitemid 44716703)
33. Joly S, Maze C, McCray PB, Guthmiller JM. 2004. Human β-defensins 2 and 3 demonstrate strain-selective activity against oral microorganisms. J Clin Microbiol 42:1024-1029. (Pubitemid 38332820)
34. Kalfa VC, Jia HP, Kunkle RA, McCray PB, Task BF, Brogden KA. 2001. Congeners of SMAP29 kill ovine pathogens and induce ultrastructural damage in bacterial cells. Antimicrob Agents Chemother 45:3256-3261.
35. Lau YE, Rozek A, Scott MG, Goosney DL, Davidson DJ, Hancock REW. 2005. Interaction and cellular localization of the human host defense peptide LL-37 with lung epithelial cells. Infect Immun 73:583-591. (Pubitemid 40041153)
36. Lee DL, Powers J-PS, Pflegerl K, Vasil ML, Hancock REW, Hodges RS. 2004. Effects of single D-amino acid substitutions on disruption of β-sheet structure and hydrophobicity in cyclic 14-residue antimicrobial peptide analogs related to gramicidin S. J Pept Res 63:69-84. (Pubitemid 38333836)
37. Mahoney MM, Lee AY, Brezinski-Caliguri DJ, Huttner KM. 1995. Molecular analysis of the sheep cathelin family reveals a novel antimicrobial peptide. FEBS Lett 377:519-522.
38. Marr AK, Gooderham WJ, Hancock REW. 2006. Antibacterial peptides for therapeutic use: obstacles and realistic outlook. Curr Opin Pharmacol 6:468-472.
39. McGwire BS, Olson CL, Tack BF, Engman DM. 2003. Killing of African trypanosomes by antimicrobial peptides. J Infect Dis 188:146-152.
40. Moon J-Y, Henzler-Wildman KA, Ramamoorthy A. 2006. Expression and purification of a recombinant LL-37 from Escherichia coli. Biochim Biophys Acta 1738:1351-1358.
41. Morassutti C, De Amicis F, Skerlavaj B, Zanetti M, Marchetti S. 2002. Production of a recombinant antimicrobial peptide in transgenic plants using a modified VMA intein expression system. FEBS Lett 519:141-146. (Pubitemid 34522007)
42. Morassutti C, De Amicis F, Bandiera A, Marchetti S. 2005. Expression of SMAP-29 cathelicidin-like peptide in bacterial cells by intein-mediated system. Prot Expr Purif 39:160-168. (Pubitemid 40084601)
43. Morin KM, Arcidiacono S, Beckwitt R, Mello CM. 2006. Recombinant expression of indolicidin concatamers in Escherichia coli. Appl Microbiol Biotechnol 70:698-704.
44. Morris MC, Depollier J, Mery J, Heitz F, Divita G. 2001. A peptide carrier for the delivery of biologically active proteins into mammalian cells. Nat Biotechnol 19:1173-1176.
45. Nielsen SL, Frimodt-Møller N, Kragelund BB, Hansen PR. 2007. Structure-activity study of the antibacterial peptide fallaxin. Protein Sci 16:1969-1976.
46. Niu M, Li X, Wei J, Cao R, Zhou B, Chen P. 2008. The molecular design of a recombinant antimicrobial peptide CP and its in vitro activity. Prot Expr Purif 57:95-100. (Pubitemid 350123054)
47. Oren Z, Shai Y. 1997. Selective lysis of bacteria but not mammalian cells by diastereomers of melittin: structure-function study. Biochemistry 36:1826-1835. (Pubitemid 27086279)
48. Orlov DS, Nguyen T, Lehrer RI. 2002. Potassium release, a useful tool for studying antimicrobial peptides. J Microbiol Methods 49:325-328.
49. Ramanathan B, Davis EG, Ross CR, Blecha F. 2002. Cathelicidins: microbicidal activity, mechanisms of action, and roles in innate immunity. Microbes Infect 4:361-372.
50. Raventós D, Taboureau O, Mygind PH, Nielsen JD, Sonksen CP, Kristensen H-H. 2005. Improving on nature's defenses: optimization and high throughput screening of antimicrobial peptides. Comb Chem High Throughput Screen 8:219-233.
51. Saido-Sakanaka H, Ishibashi J, Momotani E, Amano F, Yamakawa M. 2004. In vitro and in vivo activity of antimicrobial peptides synthesized based on the insect defensin. Peptides 25:19-27.
52. Saiman L, Tabibi S, Starner TD, Gabriel PB, Winokur PL, Jia HP, McCray PB, Tack BF. 2001. Cathelicidin peptides inhibit multiply antibiotic-resistant pathogens from patients with cystic fibrosis. Antimicrob Agents Chemother 45:2838-2844. (Pubitemid 32906680)
53. Sambri V, Marangoni A, Giacani L, Gennaro R, Murgia R, Cevenini R, Cinco M. 2002. Comparative in vitro activity of five cathelicidin-derived synthetic peptides against Leptospira, Borrelia and Treponema pallidum. J Antimicrob Chemother 50:895-902. (Pubitemid 36032810)
54. Sang Y, Ortega MT, Rune K, Xiau W, Zhang G, Soulages JL, Lushington GH, Fang J, Williams TD, Blecha F, Melgarejo T. 2007. Canine cathelicidin (K9CATH): gene cloning, expression, and biochemical activity of a novel pro-myeloid antimicrobial peptide. Dev Comp Immunol 31:1278-1296. (Pubitemid 350030289)
55. Sawai MV, Waring AJ, Kearney WR, McCray PB, Forsyth WR, Lehrer RI, Tack BF. 2002. Impact of single-residue mutations on the structure and function of ovispirin/novispirin antimicrobial peptides. Protein Eng 15:225-232.
56. Schiffer M, Edmunson AB. 1967. Use of helical wheels to represent the structures of proteins and to identify segments with helical potential. Biophys J 7:121-135.
57. Shin SY, Park EJ, Yang S-T, Jung HJ, Eom SH, Song WK, Kim Y, Hahm K-S, Kim JI. 2001. Structure-analysis of SMAP-29, a sheep leukocytes-derived antimicrobial peptide. Biochem Biophys Res Commun 285:1046-1051. (Pubitemid 32918043)
58. Skerlavaj B, Gennaro R, Bagella L, Merluzzi L, Risso A, Zanetti M. 1996. Biological characterization of two novel cathelicidin-derived peptides and identification of structural requirements for their antimicrobial and cell lytic activities. J Biol Chem 271:28375-28381. (Pubitemid 26374655)
59. Skerlavaj B, Benincasa M, Risso A, Zanetti M, Gennaro R. 1999. SMAP-29: a potent antibacterial and antifungal peptide from sheep leukocytes. FEBS Lett 463:58-62. (Pubitemid 30001718)
60. Sørensen OE, Borregaard N. 2005. Cathelicidins - nature's attempt at combinatorial chemistry. Comb Chem High Throughput Screen 8:273-280. (Pubitemid 40488605)
61. Steinstraesser L, Tack BF, Waring AJ, Hong T, Boo LM, Fan M-H, Remick DI, Su GL, Lehrer RI, Wang SC. 2002. Activity of novispirin G10 against Pseudomonas aeruginosa in vitro and in infected burns. Antimicrob Agents Chemother 46:1837-1844. (Pubitemid 34535205)
62. Sugiarto H, Yu P-L. 2007. Mechanisms of action of ostrich β-defensins against Escherichia coli. FEMS Microbiol Lett 270:195-200. (Pubitemid 46597357)
63. Tack BF, Sawai MV, Kearney WR, Robertson AD, Sherman MA, Wang W, Hong T, Boo LM, Wu H, Waring AJ, Lehrer RI. 2002. SMAP-29 has two LPS-binding sites and a central hinge. Eur J Biochem 269:1181-1189. (Pubitemid 34175377)
64. Tossi A, Tarantino C, Romeo D. 1997. Design of synthetic antimicrobial peptides based on sequence analogy and amphipathicity. Eur J Biochem 250:549-558. (Pubitemid 28012699)
65. Tossi A, Sandri L, Giangaspero A. 2000. Amphipathic, α-helical antimicrobial peptides. Biopolymers (Pept Sci) 55:4-30.
66. Travis SM, Anderson NN, Forsyth WR, Espiritu C, Conway BD, Greenberg EP, McCray PB, Lehrer RI, Welsh MJ, Tack BF. 2000. Bactericidal activity of mammalian cathelicidins-derived peptides. Infect Immun 68:2748-2755.
67. van Belkum MJ, Kok J, Venema G. 1992. Cloning, sequencing, and expression in Escherichia coli of lcnB, a third bacteriocin determinant from the lactococcal bacteriocin plasmid p9B4-6. Appl Environ Microbiol 58:572-577.
68. van der Linden DS, Short D, Dittmann A, Yu P-L. 2009. Synergistic effects of ovine-derived cathelicidins and other antimicrobials against Escherichia coli O157:H7 and Staphylococcus aureus 1056 MRSA. Biotechnol Lett 31:1265-1267.
69. Wagstaff KM, Jans DA. 2006. Protein transduction: cell penetrating peptides and their therapeutic applications. Curr Med Chem 13:1371-1387.
70. Weistroffer PL, Joly S, Srikantha R, Tack BF, Brogden KA, Guthmiller JM. 2008. SMAP29 congeners demonstrate activity against oral bacteria and reduced toxicity against oral keratinocytes. Oral Microbiol Immunol 23:89-95.
71. Xiao Y, Cai Y, Bommineni YR, Fernando SC, Prakash O, Gilliland SE, Zhang G. 2006. Identification and functional characterization of three chicken cathelicidins with potent antimicrobial activity. J Biol Chem 281:2858-2867.
72. Zanetti M. 2005. The role of cathelicidins in the innate host defenses of mammals. Curr Issues Mol Biol 7:179-196. (Pubitemid 41051685)
73. Zanetti M, Gennaro R, Scocchi M, Skerlavaj B. 2000. Structure and biology of cathelicidins. Adv Exp Med Biol 479:203-218.
74. Zanetti M, Gennaro R, Skerlavaj B, Tomasinsig L, Circo R. 2002. Cathelicidin peptides as candidates for a novel class of antimicrobials. Curr Pharm Des 8:779-793.
75. Zelezetsky I, Tossi A. 2006. Alpha-helical antimicrobial peptides-using a sequence template to guide structure-activity relationship studies. Biochim Biophys Acta 1758:1436-1449.
76. Zhu WL, Lan H, Park I-S, Kim JI, Jin HZ, Hahm K-S, Shin SY. 2006. Design and mechanism of action of a novel bacteria-selective antimicrobial peptide from the cell-penetrating peptide Pep-1. Biochem Biophys Res Commun 349:769-774.